{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:49:11Z","timestamp":1788583751466,"version":"build-2803163510"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.anndiagpath.2024.152267","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T04:24:45Z","timestamp":1705724685000},"page":"152267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["PD-L1 immunohistochemical expression in bladder urothelial cancer with SP263, SP142 and 22C3 antibodies: A comparative study"],"prefix":"10.1016","volume":"69","author":[{"given":"Panagiotis","family":"Paliogiannis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Lobrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Angelo","family":"Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Fara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriela","family":"Uras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonia","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Madonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Zinellu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152267_bb0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/cancers15030689","article-title":"Duration of immunotherapy in non-small cell lung cancer survivors: a lifelong commitment?","volume":"15","author":"Putzu","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.anndiagpath.2024.152267_bb0010","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1007\/s12325-021-01796-6","article-title":"Durvalumab plus tremelimumab in solid tumors: a systematic review","volume":"38","author":"Arru","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.anndiagpath.2024.152267_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.666624","article-title":"Are molecular alterations linked to genetic instability worth to be included as biomarkers for directing or excluding melanoma patients to immunotherapy?","volume":"11","author":"Palmieri","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152267_bb0020","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820917527","article-title":"Advances in immunotherapy for colorectal cancer: a review","volume":"13","author":"Golshani","year":"2020","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.anndiagpath.2024.152267_bb0025","first-page":"721","article-title":"Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives","volume":"15","author":"Wang","year":"2023","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152267_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13000-021-01151-x","article-title":"PD-L1 immunostaining: what pathologists need to know","volume":"16","author":"Akhtar","year":"2021","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152267_bb0035","unstructured":"NCCN Clinical Practice Guidelines in Oncology, Bladder Cancer (Version 3, 2023). https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1417. [Accessed the 03\/01\/2024]."},{"key":"10.1016\/j.anndiagpath.2024.152267_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954910","article-title":"Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection","volume":"13","author":"Munari","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.anndiagpath.2024.152267_bb0045","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejca.2018.11.007","article-title":"Performance of the Food and Drug Administration\/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab","volume":"106","author":"Eckstein","year":"2019","journal-title":"Eur J Cancer"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:36:22Z","timestamp":1761078982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":9,"alternative-id":["S1092913424000042"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152267","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-L1 immunohistochemical expression in bladder urothelial cancer with SP263, SP142 and 22C3 antibodies: A comparative study","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152267"}}